Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

Hernan Inojosa - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)
Annika Kather - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)
Katja Akgün - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)
Tjalf Ziemssen - , Department of Neurology, University Hospital Carl Gustav Carus Dresden (Author)

ORCID	/0000-0001-8799-8202/work/172572550
Scopus	85210099640